European Archives - Page 929 of 1311 - European Medical Journal

The NIACE Score: A Prognostic Indicator in Hepatocellular Carcinoma

The NIACE score is an easy-to-calculate prognostic score, and this study demonstrated that NIACE can distinguish between two subgroups with different…

Overlap Syndrome with Autoimmune Hepatitis and Primary Sclerosing Cholangitis

The autoimmune liver diseases (AILD) have been categorised classically as either autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC)…

L-carnitine Could Be Beneficial in Nonalcoholic Fatty Liver Disease Patients by Improving Choline Metabolism and Reducing Liver Biomarkers

This study investigated what effect L-carnitine supplementation could have on liver metabolites. In this study, the authors hypothesised that L-carnitine…

miRNA-21 Ablation in Mice Protects Against Gut Microbiota Dysbiosis During Cholestasis

Gut microbiota play an important role in gut–liver axis homeostasis. The understanding of the gut–liver relationship is crucial for the advances of…

Liver Fibrosis: A Clinical Update

Liver fibrosis is the common sequelae of chronic insult to the liver from any aetiology. The most common causes are alcohol-related, fatty liver disease…

The Good Use of Paracetamol: Prospective Assessment of the Knowledge of Prescribers, Pharmacists, Care Providers, and Students in a University Medical Centre

The knowledge regarding the proper use of paracetamol is insufficient for the maximum chronic dosage, the risk of paracetamol hepatotoxicity…

Neutrophil-to-Lymphocyte Ratio and Corticosteroid Response in Alcoholic Hepatitis

Treatment of alcoholic hepatitis with corticosteroids remains controversial, with recent studies indicating only a 28-day survival benefit…

A Non-invasive Way of Detecting Alzheimer’s

ALZHEIMER’S disease could be tracked through a blood test, according to a new study. The results may prove to be the first step towards a new…

Antisense Treatment Shows Hope for Genetic Form of ALS

ALTHOUGH the cause of amyotrophic lateral sclerosis (ALS) is unknown, in 10% of cases it due to genetic mutations, many of which can be single nucleotide..

EMJ Oncology 7 [Suppl 1] 2019

This review covers the inherent difficulties in stratifying early-stage breast cancer patients with regard to risk of recurrence.